Filing metadata

Accession number
0001127602-19-027392
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Aug 26, 2019
Reporting period
Aug 23, 2019
Description
Insider transaction

Explore SEC Filings Hub